Zhu Qing, Guo Ju-Tao, Seeger Christoph
Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
J Virol. 2003 Sep;77(17):9204-10. doi: 10.1128/jvi.77.17.9204-9210.2003.
The hepatitis C virus (HCV) pandemic affects the health of more than 170 million people and is the major indication for orthotopic liver transplantations. Although the human liver is the primary site for HCV replication, it is not known whether extrahepatic tissues are also infected by the virus and whether nonprimate cells are permissive for RNA replication. Because HCV exists as a quasispecies, it is conceivable that a viral population may include variants that can replicate in different cell types and in other species. We have tested this hypothesis and found that subgenomic HCV RNAs can replicate in mouse hepatoma and nonhepatic human epithelial cells. Replicons isolated from these cell lines carry new mutations that could be involved in the control of tropism of the virus. Our results demonstrated that translation and RNA-directed RNA replication of HCV do not depend on hepatocyte or primate-specific factors. Moreover, our results could open the path for the development of animal models for HCV infection.
丙型肝炎病毒(HCV)大流行影响着超过1.7亿人的健康,并且是原位肝移植的主要指征。虽然人类肝脏是HCV复制的主要部位,但尚不清楚肝外组织是否也受到该病毒感染,以及非灵长类细胞是否允许RNA复制。由于HCV以准种形式存在,可以想象病毒群体可能包括能够在不同细胞类型和其他物种中复制的变体。我们检验了这一假设,发现亚基因组HCV RNA能够在小鼠肝癌细胞和非肝源性人上皮细胞中复制。从这些细胞系分离出的复制子携带可能参与病毒嗜性控制的新突变。我们的结果表明,HCV的翻译和RNA指导的RNA复制不依赖于肝细胞或灵长类特异性因子。此外,我们的结果可能为开发HCV感染动物模型开辟道路。